Gene-environment interaction in the determination of plasma levels of fibrinogen

Fibrinolysis and Proteolysis

Volumn 11, Issue SUPPL. 1, 1997, Pages 3-7

  Humphries, S E ^a   Thomas, A ^a   Montgomery, H E ^a   Green, F ^a   Winder, A ^b   Miller, G ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ALLELE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; FEMALE; FIBRINOGEN BLOOD LEVEL; HEREDITY; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0030662061     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80013-6     Document Type: Conference Paper

References (21)

1. Thompson S G, Martin J C, Meade T W. Sources of variability in coagulation factor assays. Thromb Haemost 1987; 58: 1073-1077.
2. Hamsten A, Iselius L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentrarion. Lancet 1987; ii: 998-990.
3. Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet 1989; 36: 229-235.
4. Reed T, Tracey R P, Fabsitz R R. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clin Genet 1994; 45: 71-77.
5. Freidlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibringen variability in Israeli families. The Kibbutzim Family Study. Am J Hum Genet 1995; 56: 1194-1206.
6. Roy S N, Mukhopadhyay G, Redman C M. Regulation of fibrinogen assembly. Transfection of HepG2 cells with Bβ cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393.
7. Dalmon J, Laurent M, Courtios G. The human β fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6 responsive element. Mol Cell Biol 1993; 13: 1183-1193.
8. Thomas A, Kelleher C, Green F, Meade T W, Humphries S E. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and nonsmokers. Thromb Haem 1991; 65: 487-490.
9. Conner J M, Fowkes F G R, Wood J, Smith F B, Donnon P T, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992;29: 480-482.
10. Green F, Hamsten A, Blomback M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-920.
11. Scarabin P-Y, Bara L, Ricard S, Poirer O, Cambou J P, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of mtocardial infarction. The ECTIM Study. Arterioscler and Thromb 1993;13: 886-891.
12. 453-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: Evidence for gender - genotype - environment interaction. Arterioscler and Thromb 15: 96-104.
13. Iso H, Folsom A, Winklemann J C, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Lida M, Komachi. Polymorphisms of the beta fibrinbogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemostas 1995; 73: 106-111
14. Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assman G. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995; 77: 209-215.
15. 455 polymorphism, age smoking. Clin Genet 1996 ; in press
16. Meade T W, Mellows S, Brozovic M, Miller G J, Chakrabarti R R, North W R, Haines A P, Stirling Y, Imeson J D, Thompson S G. Hemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
17. Kannel W B, Wolf P A, Catelli W P, D'Agostino R B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-1186.
18. Simonsick E M, Lafferty M E, Phillips C L, Mendes de Leon C F, Kasl S V, Seeman T E, Fillenbaum G, Hebert P, Lemke J H. Risk due to inactivity in physically capable older adults. Am J Public Health 1993; 83: 1443-1450.
19. Stratton J R, Chandler W L, Schwartz R S, Cerqueira M D, Levy W C, Kahn S E, Larson V G, Cain K C, Beard J C, Abrass I B. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692-1697.
20. Montgomery H E, Clarkson P, Nwose O M, Mikalidis D P, Jagroop I A, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb C, World M, McEwan J R, Winder A, Humphries S. The acute rise in serum fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioslcr, Thromb, Vasc Biol 1996; 16: 386-391.
21. Haines A P, Howarth D, North W R S, Goldenberg E, Stirling Y, Meade T W, Raftery E B, Craig M W M. Haemostatic variables and outcome of acute myocardial infarction. Thromb Haemost 1983; 50: 800-803.